SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPatria Private Regulatory News (PPET)

Share Price Information for Patria Private (PPET)

Share Price is delayed by 15 minutes
Get Live Data
616.00    12.00 (1.99%)
Bid:
604.00
Ask:
616.00
Spread: 12.00 (1.987%)
Market Cap: £900.93m
PPET Live PriceLast checked at - London Stock Exchange

Intraday Patria Private Share Chart

Net Asset Value(s)

3 Mar 2026 07:00

RNS Number : 9899U
Patria Private Equity Trust PLC
03 March 2026
Β 

Patria Private Equity Trust plc

Legal Entity Identifier (LEI): 2138004MK7VPTZ99EV13

Β 

3 March 2026

ESTIMATED NET ASSET VALUE AT 31 JANUARY 2026

Patria Private Equity Trust plc ("PPET" or "the Company") announces its estimated net asset value ("NAV") at 31 January 2026

Β· Estimated NAV at 31 January 2026 was 829.2 pence per share (estimated NAV at 31 December 2025 was 840.2 pence per share)

Β· Excluding new investments, 96.3% by value of portfolio dated 30 September 2025 (estimated NAV at 31 December 2025 was 96.3% dated 30 September 2025)

Β· Third interim dividend of 4.4 pence per share paid on 23 January 2026

Β· PPET paid Β£10.4 million of drawdowns and received Β£3.5 million of distributions during the month of January

Β· PPET made no new investments in January 2026

Β· Outstanding commitments of Β£728.8 million at 31 January 2026

Β· Short term resources (cash balances and undrawn credit facilities) were Β£259.4 million as at 31 January 2026

Β 

Estimated NAV

At 31 January 2026, PPET's estimated NAV was 829.2 pence per share (estimated net assets Β£1,228.5 million)[1], representing a 1.3% per share decrease from the estimated NAV at 31 December 2025 of 840.2 pence per share (estimated net assets Β£1,248.5 million). The 11.0 pence decrease in NAV per share reflected losses arising primarily from a 0.5% depreciation in the euro versus sterling and a 2.2% depreciation in the US dollar versus sterling during January, in addition to the third interim dividend payment of 4.4 pence per share on 23 January 2026. The total payment made for the third interim dividend was Β£6.5 million.

Β 

Β 

Performance

PPET's total return and comparator reference performance as at 31 January 2026 was as follows:

Performance over the last

Β 

Β 

6 months

1 year

3 years

5 years

10 years

Since

Inception

NAV Total Return[2]

5.4%

8.1%

20.8%

91.8%

266.2%

1136.1%

Share Price Total Return[3]

15.1%

14.2%

45.7%

91.2%

329.4%

947.9%

FTSE All-Share Index[4]

12.7%

21.1%

44.5%

80.8%

137.6%

363.0%

Performance in the 12 months to

Β 

31 Jan 2026

31 Jan 2025

31 Jan 2024

31 Jan 2023

31 Jan 2022

NAV Total Return2

8.1%

7.0%

4.5%

14.6%

39.1%

Share Price Total Return3

14.2%

13.9%

12.0%

-11.2%

47.9%

FTSE All-Share Index4

21.1%

17.1%

1.9%

5.2%

18.9%

Β 

Investment activity

As advised in the December 2025 NAV annoucement, PPET made a final payment of Β£1.7 million to the seller for the remainder of the interests relating to Project Captain.Β 

Portfolio cashflows

PPET paid Β£10.4 million of drawdowns during the month of January, of which Β£10.2 million related to primary investments, Β£0.1 million related to secondary investments and Β£0.2 million related to direct investments.

Notable drawdowns in the primary fund portfolio during the month include:

Β· Investindustrial VIII SCSp: to fund investment into Piovan, a global leader in the design, manufacture and installation of systems that automate the storage, transport and processing of polymers, plastic powders, and food ingredients; and

Β· Investindustrial Growth III: to fund a follow-on investment into Virospack, a leading manufacturer based in Barcelona specialising in cosmetic packaging solutions.

PPET received Β£3.5 million of distributions during the month of January, of which Β£2.3 million related to primary funds and Β£1.2 million related to secondary investments.

Notable realisations the month included:

Β· PAI Strategic Partnerships SCSp: proceeds from the exit of Marcolin, an Italian eyewear manufacturer; and

Β· ArchiMed - Med Platform 2: proceeds from a refinancing of Jeisys Medical, a company which specialises in non-invasive aesthetic medicine devices.

Commitments

The Company had Β£728.8 million of outstanding commitments at 31 January 2026. The Manager believes that around Β£94.0 million of the Company's existing outstanding commitments are unlikely to be drawn.

Β 

Credit facility and cash balances

The Company has a Β£400.0 million syndicated revolving credit facility. The facility is provided by The Royal Bank of Scotland International Limited, Societe Generale, State Street Bank International GmbH, State Street Bank & Trust Company and Banco Santander, S.A. On 29 January 2026, Banco Santander, S.A. transferred part of their commitment to State Street Bank & Trust Company, who have increased their commitment. The facility is due to expire in February 2028.Β 

The Company made no repayments to or drawdowns from the facility during the month of January, with a total of Β£162.4 million drawn at 31 January 2026. The remaining undrawn balance of the facility at 31 January 2026 was therefore Β£237.6 million.

In addition, the Company had cash balances of Β£21.8 million at 31 January 2026. Accordingly, short term resources, calculated as the total of cash balances and the undrawn balance of the credit facility, were Β£259.4 million as at 31 January 2026.

Β 

Share Buybacks

Pursuant to the Company's share buyback programme, the Company bought back 445,000 ordinary shares into treasury during January. The positive effect of the buyback programme is reflected within the movement in NAV.

Β 

For further information please contact:

Β 

Patria Private Equity Trust plc

PPET.InvestorRelations@patria.com

Alan Gauld (Lead Manager)

Amber Sarafilovic (Marketing & Investor Relations)

Paul Evitt (Company Secretary)

Β 

Investec Bank plc

+44 (0)20 7597 4000

Lucy Lewis

Tom Skinner

Denis Flanagan

Β 

SEC Newgate

+44 (0)20 3757 6872

Sally Walton

PPET@secnewgate.co.uk

Β 

Notes:-

Patria Private Equity Trust plc is an investment company managed by Patria Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under sections 1158-1165 of the Corporation Tax Act 2010.

Additional detail about PPET's NAV and investment diversification can be found on PPET's website (www.patriaprivateequitytrust.com). Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website is incorporated into, or forms part of, this announcement.

Β 


[1] PPET's valuation policy for private equity funds and direct investments is based on the latest valuations reported by the managers of the funds and direct investments in which the Company has interests. In the case of PPET's valuation at 31 January 2026, excluding new investments, 96.3% by value of the portfolio valuations were dated 30 September 2025. The value of the portfolio is therefore calculated as the 30 September 2025 valuation, adjusted for subsequent cashflows over the period to 31 January 2026.

Β 

[2] NAV Total Return assumes reinvestment of dividends in the NAV of the Company on the date on which that dividend goes ex-dividend and monthly compounding

[3] Share Price Total Return assumes reinvestment of dividends in the share price of the Company on the date on which that dividend goes ex-dividend. Source: London Stock Exchange Group Workspace

[4] Comparator Index - The Company is not managed with direct reference to any index or its constituents. Source: London Stock Exchange Group Workspace

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
NAVUPUUCWUPQGAP
Date   Source Headline
8th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 202611:38 amRNSTotal Voting Rights
28th May 20267:00 amRNSTransaction in Own Shares
26th May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTransaction in Own Shares
7th May 20263:15 pmRNS-RQuotedData's In The HotSeat
7th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSESTIMATED NET ASSET VALUE AT 31 MARCH 2026
1st May 202611:15 amRNSTotal Voting Rights
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 202612:15 pmRNSQuarterly Disclosure
14th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20269:07 amRNSNet Asset Value(s)
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 202611:49 amRNSTotal Voting Rights
1st Apr 20267:00 amRNSNotice of Capital Markets Event
31st Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20262:45 pmRNSPPET Board Succession Directorate change
25th Mar 20262:36 pmRNSResult of AGM
23rd Mar 202611:11 amRNSDirector/PDMR Shareholding
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 202611:44 amRNSHolding(s) in Company
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20263:33 pmRNSDECLARATION OF FIRST INTERIM DIVIDEND
9th Mar 20263:33 pmRNSDECLARATION OF FIRST INTERIM DIVIDEND
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSNet Asset Value(s)
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20262:44 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.